STEPHEN PATRICK to Opiate Substitution Treatment
This is a "connection" page, showing publications STEPHEN PATRICK has written about Opiate Substitution Treatment.
Connection Strength
6.741
-
Cost-Effectiveness of Treatment for Opioid Use Disorder in Pregnancy and Its Impact on Birth Outcomes. JAMA Pediatr. 2025 Nov 01; 179(11):1203-1216.
Score: 0.857
-
Buprenorphine Treatment in Pregnancy and Maternal-Infant Outcomes. JAMA Health Forum. 2025 04 27; 6(4.11):e251814.
Score: 0.827
-
"Just Google It": A Qualitative Study of Reproductive-Age Women's Stigmatizing Experiences When Accessing Buprenorphine for Opioid Use Disorder. Womens Health Issues. 2025 Jan-Feb; 35(1):45-53.
Score: 0.803
-
Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder. JAMA Netw Open. 2020 08 03; 3(8):e2013456.
Score: 0.596
-
Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: A retrospective study of admissions to treatment centers in the United States. PLoS Med. 2020 05; 17(5):e1003119.
Score: 0.587
-
Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states. Subst Abus. 2019; 40(3):356-362.
Score: 0.525
-
Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome. J Pediatr. 2018 08; 199:151-157.e1.
Score: 0.510
-
The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care. Arch Dis Child Fetal Neonatal Ed. 2017 Mar; 102(2):F183-F187.
Score: 0.465
-
Use of Medications for Opioid Use Disorder and Child Welfare Outcomes. JAMA Health Forum. 2024 07 05; 5(7):e241768.
Score: 0.195
-
Buprenorphine Out-of-Pocket Costs and Discontinuation in Privately Insured Adults With Opioid Use Disorder. JAMA Intern Med. 2023 09 01; 183(9):1023-1026.
Score: 0.184
-
County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder. Med Care. 2023 12 01; 61(12):816-821.
Score: 0.181
-
Prevalence of Buprenorphine Providers Requiring Cash Payment From Insured Women Seeking Opioid Use Disorder Treatment. Med Care. 2023 06 01; 61(6):377-383.
Score: 0.180
-
Laws Forbidding Pregnancy Discrimination in Substance Use Disorder Treatment Are Not Associated With Treatment Access. J Addict Med. 2022 May-Jun 01; 16(3):364-367.
Score: 0.168
-
Disparities in receipt of medications for opioid use disorder among pregnant women. Subst Abus. 2022; 43(1):508-513.
Score: 0.159
-
Development and Validation of a Model to Predict Neonatal Abstinence Syndrome. J Pediatr. 2021 02; 229:154-160.e6.
Score: 0.151
-
Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates. Health Aff (Millwood). 2016 07 01; 35(7):1324-32.
Score: 0.112
-
Improving Care for Neonatal Abstinence Syndrome. Pediatrics. 2016 05; 137(5).
Score: 0.111
-
Association of Opioid Use Disorder-Related Service Trajectories During Pregnancy and Postpartum Health Service Use: A Group-Based Multitrajectory Modeling Study. J Addict Med. 2025 Jul-Aug 01; 19(4):403-411.
Score: 0.051
-
Treatment access for opioid use disorder among women with medicaid in Florida. Drug Alcohol Depend. 2023 05 01; 246:109854.
Score: 0.045
-
Neonatal abstinence syndrome. Nat Rev Dis Primers. 2018 11 22; 4(1):47.
Score: 0.033